To determine the success of management and follow-up of reproductive health in a cohort of women diagnosed with enhanced myometrial vascularisation. This is an ambispective cohort study based on data collected at the Fundación Santa Fe de Bogotá University Hospital between 2018 and 2020. Women with abnormal uterine bleeding associated with retained products of conception, with a diagnosis of enhanced myometrial vascularity by transvaginal ultrasound were selected. Enhanced myometrial vascularity was defined by notable turbulent flow in tangle of vessels extending into the myometrium and confirmed by histopathology. Treatment success was defined in those cases that corrected uterine bleeding after the medical or surgical approach. The number of women with new pregnancies and delivery was determined. Between 2018 and 2020, our hospital generated more than 13,000 consults associated with pregnancy. However, about 1% of these were associated with abnormal uterine bleeding and increased myometrial vascularity, with 13 cases identified. These women had an average age of 34.3 (±) 5,3 years, and transvaginal ultrasound with Doppler enhanced myometrial vascularisation was observed in 100% of the cases. Only 76% of the patients received medical management, however, 100% of the patients required definitive management with hysteroscopy due to recurrent abundant bleeding. By histopathology, all 13 patients were diagnosed with chorionic villi remains. In reproductive follow-up, 23% (3) have reported a new spontaneous pregnancy. In our experience, we consider that hysteroscopic surgical management of this pathology could be considered as first line. Further observational studies with robust data are necessary to strengthen this hypothesis.